Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Asian Journal of Endoscopic Surgery|December 1, 2020
How to reduce the risk of organ injuries during surgical instrument insertion in laparoscopic surgery: Pushing/pressing force analysis using forceps with sensorsKazuhide Makiyama, Kimito Osaka, Azumi Araki, et al.Molecular and Clinical Oncology|August 17, 2018
Oxidative stress marker 8-hydroxyguanosine is more highly expressed in prostate cancer than in benign prostatic hyperplasiaShinji Ohtake, Takashi Kawahara, Yukari Ishiguro, et al.BMC Urology|April 20, 2018
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case reportGo Noguchi, Sohgo Tsutsumi, Masato Yasui, et al.Case Reports in Oncological Medicine|July 7, 2018
Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial NephrectomyShinji Ohtake, Takashi Kawahara, Go Noguchi, et al.Molecules (Basel, Switzerland)|December 11, 2022
CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma CellsNoah Trac, Hyun Seok Oh, Leila Izzy Jones, et al.Urology|November 20, 2022
Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant CandidatesPeter Muraki, Cory Lee, Neal Patel, et al.Plos One|January 3, 2020
A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinomaGo Noguchi, Takashi Kawahara, Kota Kobayashi, et al.Journal of Kidney Cancer and VHL|October 31, 2022
Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHLAileen Arevalo, Neal Patel, Peter Muraki, et al.Urologia Internationalis|October 17, 2018
Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naïve Prostate CancerYasuhide Miyoshi, Mari Ohtaka, Takashi Kawahara, et al.Biomed Research International|May 13, 2017
A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin TherapyRyo Kasahara, Takashi Kawahara, Shinji Ohtake, et al.Pageof 4